<Suppliers Price>

Clofibric acid

Names

[ CAS No. ]:
882-09-7

[ Name ]:
Clofibric acid

[Synonym ]:
Clofibrin
Regulipid
a-(p-Chlorophenoxy)isobutyric Acid
2-(p-chlorophenoxy)-isobutyric acid
PCIB
4-CPIB
2-(4-Chlorophenoxy)-2-methylpropanoic acid
Clofibric
2-(4-chlorophenoxy)isobutyric acid
Chlorofibrinic acid
Arteriohom
PCPIB
Clofibric acid
Chlorfibrinic acid
EINECS 212-925-9
Propanoic acid, 2-(4-chlorophenoxy)-2-methyl-
MFCD00004192
4-Chlorophenoxy-iso-butyric Acid
2-(p-Chlorophenoxy)-2-methylpropionic Acid
2-(4-Chlorophenoxy)-2-methylpropionic acid
Clofibric acid [DCF:INN]
Clofibrinic acid
Regadrin

Biological Activity

[Description]:

Clofibric acid is a plant growth regulator against the plant hormone auxin.

[Related Catalog]:

Signaling Pathways >> Others >> Others
Research Areas >> Others

[Related Small Molecules]

Captisol | Cyclosporin A | H2DCFDA | 0MPTP hydrochloride | GW4869 | Etomoxir | TD139 | Mitoquinone mesylate | GSK2795039 | JC-1 | BAPTA-AM | AP 20187 | Setanaxib (GKT137831) | D-Luciferin | Crotaline

Chemical & Physical Properties

[ Density]:
1.3±0.1 g/cm3

[ Boiling Point ]:
324.1±17.0 °C at 760 mmHg

[ Melting Point ]:
120-122 °C(lit.)

[ Molecular Formula ]:
C10H11ClO3

[ Molecular Weight ]:
214.645

[ Flash Point ]:
149.8±20.9 °C

[ Exact Mass ]:
214.039673

[ PSA ]:
46.53000

[ LogP ]:
2.72

[ Vapour Pressure ]:
0.0±0.7 mmHg at 25°C

[ Index of Refraction ]:
1.541

[ Storage condition ]:
Store at RT

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
UE9455000
CHEMICAL NAME :
Propionic acid, 2-(p-chlorophenoxy)-2-methyl-
CAS REGISTRY NUMBER :
882-09-7
BEILSTEIN REFERENCE NO. :
1874067
LAST UPDATED :
199612
DATA ITEMS CITED :
10
MOLECULAR FORMULA :
C10-H11-Cl-O3
MOLECULAR WEIGHT :
214.66
WISWESSER LINE NOTATION :
QVX1&1&OR DG

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Human
DOSE/DURATION :
260 mg/kg/91D
TOXIC EFFECTS :
Liver - other changes
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
897 mg/kg
TOXIC EFFECTS :
Liver - other changes
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
727 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
120 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1170 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
290 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
683 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
219 gm/kg/2Y-C
TOXIC EFFECTS :
Liver - changes in liver weight Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) Biochemical - Metabolism (Intermediary) - lipids including transport
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
17750 mg/kg/10W-C
TOXIC EFFECTS :
Liver - other changes Liver - changes in liver weight Biochemical - Effect on specific coenzyme - CoA

MUTATION DATA

TEST SYSTEM :
Rodent - rat
DOSE/DURATION :
2100 mg/kg/1W (Continuous)
REFERENCE :
CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- Volume(issue)/page/year: 12,1557,1991

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H302

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves

[ Hazard Codes ]:
Xn: Harmful;Xi: Irritant;

[ Risk Phrases ]:
R22

[ Safety Phrases ]:
S36-S24/25

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

[ RTECS ]:
UE9455000

[ HS Code ]:
2918990090

Synthetic Route

Precursor & DownStream

Customs

[ HS Code ]: 2918990090

[ Summary ]:
2918990090. other carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

Articles

Determination of selected pharmaceuticals in tap water and drinking water treatment plant by high-performance liquid chromatography-triple quadrupole mass spectrometer in Beijing, China.

Environ. Sci. Pollut. Res. Int. 22(3) , 1854-67, (2015)

A simultaneous determination method of 14 multi-class pharmaceuticals using solid-phase extraction (SPE) followed by high-performance liquid chromatography-tandem mass spectrometer (HPLC-MS/MS) was es...

Emerging organic contaminants in coastal waters: anthropogenic impact, environmental release and ecological risk.

Mar. Pollut. Bull. 85(2) , 391-9, (2014)

This study provides a first estimate of the sources, distribution, and risk presented by emerging organic contaminants (EOCs) in coastal waters off southwestern Taiwan. Ten illicit drugs, seven nonste...

Enzymatic characterization of ELOVL1, a key enzyme in very long-chain fatty acid synthesis.

Biochim. Biophys. Acta 1851(2) , 231-7, (2015)

X-linked adrenoleukodystrophy (X-ALD) is a neurometabolic disease that is caused by mutations in the ABCD1 gene. ABCD1 protein deficiency impairs peroxisomal very long-chain fatty acid (VLCFA) degrada...


More Articles


Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.